Carotid Intima Media Thickness, Inflammatory Markers, and Endothelial Activation Markers in HIV Patients with Lipoatrophy Increased at 48 Weeks Regardless of Use of Rosiglitazone or Placebo

Rosiglitazone may be useful for the treatment of antiretroviral therapy-associated lipoatrophy, but an association with cardiovascular disease (CVD) has been questioned in diabetics. We evaluated rosiglitazone's effect on surrogate markers of CVD in HIV-infected individuals with lipoatrophy. HI...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Tungsiripat, Marisa, El-Bejjani, Dalia, Rizk, Nesrine, Dogra, Vikram, O'Riordan, Mary Ann, Ross, Allison C., Hileman, Corrilynn, Storer, Norma, Harrill, Danielle, McComsey, Grace A.
Format: Artigo
Langue:Inglês
Publié: Mary Ann Liebert, Inc. 2011
Sujets:
Preclinical Studies/Drug Development
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3064528/
https://ncbi.nlm.nih.gov/pubmed/20969457
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/aid.2010.0187
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires